Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

LecTec cleared to proceed with clinical testing of smoking cessation product

Nov. 22, 1996

Cocaine vaccine nearing clinic

Nov. 8, 1996

New therapeutic for smoking cessation to enter pivotal trials

Oct. 25, 1996

Nicotine inhaler for smoking cessation: Clinical trial results

Oct. 25, 1996

Cangene acquires iron chelator from Apotex

Oct. 18, 1996

Japanese scientists discover potential agent for siderosis

Oct. 11, 1996

Cocaine vaccine proven effective in animal model

Oct. 11, 1996

First launch for inhaled smoking cessation product

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Nicotine nasal spray codevelopment agreement

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...